Acute Migraine Medications and Evolution From Episodic to Chronic Migraine: A Longitudinal Population‐Based Study

@article{Bigal2008AcuteMM,
  title={Acute Migraine Medications and Evolution From Episodic to Chronic Migraine: A Longitudinal Population‐Based Study},
  author={M. Bigal and D. Serrano and D. Buse and A. Scher and W. Stewart and R. Lipton},
  journal={Headache: The Journal of Head and Face Pain},
  year={2008},
  volume={48}
}
  • M. Bigal, D. Serrano, +3 authors R. Lipton
  • Published 2008
  • Medicine
  • Headache: The Journal of Head and Face Pain
    • Background.— Though symptomatic medication overuse is believed to play a major role in progression from episodic to chronic or transformed migraine (TM), population‐based longitudinal data on these agents are limited. 
    View on Wiley
    onlinelibrary.wiley.com
    413 Citations
    Highly Influential Citations
    13
    Background Citations
    142
    Methods Citations
    10
    Results Citations
    6

    Paper Mentions

    Interventional Clinical Trial
    Efficacy of OnabotulinumtoxinA in Migraine
    Population studies estimate that patients who have episodic migraine transition to chronic migraine at a rate of about 2.5% per year. CM is a devastating disorder associated to… Expand
    ConditionsMigraine
    InterventionDrug
    IRCCS National Neurological Institute "C. Mondino" Foundation
    March 2018 - May 2020
    413 Citations
    Citation Type

    Citation Type

    Episodic and Chronic Migraine in Primary Care
    • 3
    Discontinuation of Acute Prescription Medication for Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study
    • 9
    Clinical Subtypes of Medication Overuse Headache – Findings From a Large Cohort
    • 4
    Examination of Unmet Treatment Needs Among Persons With Episodic Migraine: Results of the American Migraine Prevalence and Prevention (AMPP) Study
    • 93
    Chronic Migraine Prevalence, Disability, and Sociodemographic Factors: Results From the American Migraine Prevalence and Prevention Study
    • 289
    • PDF
    Persistent Frequent Nausea Is Associated With Progression to Chronic Migraine: AMPP Study Results
    • 34
    Adding Additional Acute Medications to a Triptan Regimen for Migraine and Observed Changes in Headache‐Related Disability: Results From the American Migraine Prevalence and Prevention (AMPP) Study
    • 16
    Predicting Inadequate Response to Acute Migraine Medication: Results From the American Migraine Prevalence and Prevention (AMPP) Study
    • 31
    Burden of increasing opioid use in the treatment of migraine: Results from the Migraine in America Symptoms and Treatment Study
    Economic Burden of Transformed Migraine: Results From the American Migraine Prevalence and Prevention (AMPP) Study
    • 219

    References

    SHOWING 1-10 OF 54 REFERENCES
    Epidemiology of Chronic Daily Headache in the General Population
    • 645
    Concepts and Mechanisms of Migraine Chronification
    • 116
    Cutaneous allodynia in the migraine population
    • 341
    Modifiable Risk Factors for Migraine Progression (or for Chronic Daily Headaches)—Clinical Lessons
    • 68
    Does Chronic Daily Headache Arise De Novo in Association With Regular Use of Analgesics?
    • 237
    Analgesic Rebound Headache in Clinical Practice: Data From a Physician Survey
    • 134
    Opiate Use to Control Bowel Motility May Induce Chronic Daily Headache in Patients With Migraine
    • 150
    Transformed Migraine and Medication Overuse in a Tertiary Headache Centre — Clinical Characteristics and Treatment Outcomes
    • 227
    Factors associated with the onset and remission of chronic daily headache in a population-based study
    • 584
    • PDF
    New Appendix Criteria Open for a Broader Concept of Chronic Migraine
    • 630
    • PDF